CEO of MEDNAX, INC. (MD, Financial) Roger Md Medel sells 24,000 shares of MD on 01/05/2010 at an average price of $60.45 a share.
Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives. Mednax, Inc. has a market cap of $2.75 billion; its shares were traded at around $59.17 with a P/E ratio of 16.9 and P/S ratio of 2.6. GuruFocus rated Mednax, Inc. the business predictability rank of 5-star.
MD is in the portfolios of David Dreman of Dreman Value Management, Richard Pzena of Pzena Investment Management LLC, Chuck Royce of ROYCE & ASSOCIATES, Jeremy Grantham of GMO LLC.
Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives. Mednax, Inc. has a market cap of $2.75 billion; its shares were traded at around $59.17 with a P/E ratio of 16.9 and P/S ratio of 2.6. GuruFocus rated Mednax, Inc. the business predictability rank of 5-star.
MD is in the portfolios of David Dreman of Dreman Value Management, Richard Pzena of Pzena Investment Management LLC, Chuck Royce of ROYCE & ASSOCIATES, Jeremy Grantham of GMO LLC.
CEO Recent Trades:
- Sell:: CEO Roger Md Medel sold 46,427 shares of MD stock on 12/30/2009 at the average price of 60.88, the price of the stock has decreased by 2.81% since.
- Sell:: CEO Roger Md Medel sold 57,525 shares of MD stock on 12/28/2009 at the average price of 60.54, the price of the stock has decreased by 2.26% since.
- Sell:: CEO Roger Md Medel sold 48,899 shares of MD stock on 12/08/2009 at the average price of 57.09, the price of the stock has increased by 3.64% since.
- Sell:: CEO Roger Md Medel sold 51,101 shares of MD stock on 12/03/2009 at the average price of 57.06, the price of the stock has increased by 3.7% since.
- Sell:: CEO Roger Md Medel sold 40,000 shares of MD stock on 09/09/2009 at the average price of 51.19, the price of the stock has increased by 15.59% since.
CFO Recent Trades:
- Sell:: CFO Karl B Wagner sold 13,907 shares of MD stock on 09/02/2009 at the average price of 52.02, the price of the stock has increased by 13.74% since.
Directors and Officers Recent Trades:
- Sell:: President, Pediatrix Division Frederick V Md Miller sold 5,735 shares of MD stock on 12/23/2009 at the average price of 59.83, the price of the stock has decreased by 1.1% since.
- Sell:: President, Pediatrix Division Frederick V Md Miller sold 1,104 shares of MD stock on 12/22/2009 at the average price of 59.7, the price of the stock has decreased by 0.89% since.
- Sell:: President, Pediatrix Division Frederick V Md Miller sold 3,786 shares of MD stock on 12/16/2009 at the average price of 59.79, the price of the stock has decreased by 1.04% since.
- Sell:: President, Pediatrix Division Frederick V Md Miller sold 2,570 shares of MD stock on 12/01/2009 at the average price of 56.58, the price of the stock has increased by 4.58% since.
- Sell:: Director Paul G Gabos sold 44,000 shares of MD stock on 11/11/2009 at the average price of 56.01, the price of the stock has increased by 5.64% since.
